Literature DB >> 7451668

Heparin stability: effects of diluent, heparin activity, container, and pH.

K T Goodall, C C Chooi, A S Gallus.   

Abstract

The effects have been studied of diluent, heparin activity after dilution, container, and pH on the stability of heparin solutions stored under conditions resembling those present during heparin infusion by intravenous drip or syringe pump. Heparin activity was measured by activated partial thromboplastin time and thrombin clotting time (and, in one set of studies, also by factor Xa inhibitor assay and protamine sulphate neutralisation). Heparin activity was stable for 6 hours regardless of storage conditions. After 24 hours heparin activity was stable when the drug was diluted in 0.9% saline and stored in plastic, but a small loss of activity was observed in several studies after dilution in 5% dextrose or storage in glass. A more extensive comparison confirmed a 3-5% loss in heparin activity over 24 hours after dilution in 5% dextrose. Changing the pH to 3.5 or 10.0 had little effect on storage stability. We conclude that heparin activity in vitro remains stable during short infusions but recommend dilution in 0.9% saline and a plastic container when a heparin solution is infused over 24 hours.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451668      PMCID: PMC1146377          DOI: 10.1136/jcp.33.12.1206

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Anticoagulant activity of heparin in intravenous fluids.

Authors:  T Okuno; C A Nelson
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  The titration of heparin with protamine.

Authors:  I REFN; L VESTERGAARD
Journal:  Scand J Clin Lab Invest       Date:  1954       Impact factor: 1.713

3.  Plasma heparin: a unique, practical, submicrogram-sensitive assay.

Authors:  E T Yin; S Wessler; J V Butler
Journal:  J Lab Clin Med       Date:  1973-02

4.  The influence of drugs upon the anticoagulant activity of heparin.

Authors:  E D Hodby; J Hirsh; C Adeniyi-Jones
Journal:  Can Med Assoc J       Date:  1972-03-04       Impact factor: 8.262

5.  Heparin in acid solutions.

Authors:  S L Stock; N Warner
Journal:  Br Med J       Date:  1971-07-31

6.  Effect of pH on the stability of heparin in 5% dextrose solutions.

Authors:  R T Joy; M L Hyneck; R R Berardi; N F Ho
Journal:  Am J Hosp Pharm       Date:  1979-05

7.  Intravenous infusions of heparin and penicillins.

Authors:  J Jacobs; D Kletter; E Superstine; K R Hill; B Lynn; R A Webb
Journal:  J Clin Pathol       Date:  1973-10       Impact factor: 3.411

8.  Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.

Authors:  J M Chessells; T A Braithwaite; D A Chamberlain
Journal:  Br Med J       Date:  1972-04-08
  8 in total
  3 in total

1.  Effectiveness of Unfractionated Heparin in Normal Saline versus Dextrose for Achieving and Maintaining Therapeutic Anti-Factor Xa Levels in Patients with Non-ST-Elevation Acute Coronary Syndrome.

Authors:  Amanda C Jacques; Colleen Lougheed; Erika Macdonald; Alan Karovitch; Pierre Giguère
Journal:  Can J Hosp Pharm       Date:  2013-11

2.  Biodegradable MRI Visible Drug Eluting Stent Reinforced by Metal Organic Frameworks.

Authors:  Rezvani Alanagh Hamideh; Babak Akbari; Parinaz Fathi; Santosh K Misra; Andre Sutrisno; Fan Lam; Dipanjan Pan
Journal:  Adv Healthc Mater       Date:  2020-06-16       Impact factor: 11.092

Review 3.  Oriented Immobilization of Protein Templates: A New Trend in Surface Imprinting.

Authors:  Jakub Kalecki; Zofia Iskierko; Maciej Cieplak; Piyush S Sharma
Journal:  ACS Sens       Date:  2020-11-22       Impact factor: 7.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.